Clinical Trial Update: Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating harms and benefits of endocrine therapy in patients aged 70 and older with lower-risk breast cancer. The study is spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Endocrine therapy

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer | Phase 4 | Status: ACTIVE_NOT_RECRUITING